WHO: 12 Infections Behind 12% of New Cancer Cases

A new IARC study in The Lancet Oncology links 2.3 million of the world's 20 million new 2024 cancer cases to twelve preventable infections.

@sharedot

WHO: 12 Infections Behind 12% of New Cancer Cases

By @sharedot · · 8 pages

  • Health
  • Cancer
  • Infectious Disease
  • Public Health

A new IARC study in The Lancet Oncology links 2.3 million of the world's 20 million new 2024 cancer cases to twelve preventable infections.

One in Eight Cancers Tied to Infection

The analysis evaluated twelve infectious agents classified as Group 1 human carcinogens, spanning viruses, bacteria and parasites.

The headline figure held essentially steady from IARC's previous 2018 assessment of 13%, underscoring persistent gaps in vaccination uptake, screening and treatment access. Time reports the finding raises the hope that preventing infection could prevent entire categories of malignancy.

H. pylori Edges Out HPV as Top Cause

The study's most surprising result is the ranking: Helicobacter pylori, a stomach bacterium most people never know they carry, was linked to roughly 760,000 new cancer cases, slightly more than HPV's 750,000, per NCHStats.

Together the top two pathogens caused about 1.5 million cases, two-thirds of the infection-linked total.

Why a Stomach Bug Turns Malignant

Most people infected with any of these pathogens never develop cancer, and malignancies often take decades to emerge.

Clarin reports that the mechanisms differ by agent: H. pylori causes chronic inflammation and tissue damage while producing toxins that destabilize control of cell growth; HPV and EBV integrate viral oncoproteins that interfere with tumor suppressors like p53; and HIV degrades immune surveillance, allowing other oncogenic viruses such as KSHV and HPV to replicate unimpeded.

Time notes that EBV hides inside B cells and blocks normal cellular housecleaning, driving them to continually grow, according to University of Birmingham virologist Claire Shannon-Lowe.

The Burden Falls Heaviest on Lower-Income Nations

Low- and middle-income nations bore 77% of all infection-attributable cancer diagnoses, Clarin reports. Eastern Asia alone accounted for 990,000 cases, 42% of the global total, driven by H. pylori stomach cancers and hepatitis B liver cancers across China, Japan, South Korea and Mongolia.

In Sub-Saharan Africa, 14% of all cancer diagnoses were HPV-driven, alongside elevated Kaposi's sarcoma rates.

Vaccines, Antibiotics and Cures Already Exist

Unlike genetic cancer risks, most infection-related cancers can be prevented or treated with existing tools.

The hepatitis B vaccine, developed as the first vaccine against cancer, is given in a three-dose infant series starting within 24 hours of birth, and the HPV vaccine approved 20 years ago protects against the strains behind most cervical cancers, Time reports.

H. pylori can be cleared with antibiotics, and NCHStats cites a large Chinese study in which treatment cut stomach cancer cases nearly in half over 22 years. Direct-acting antivirals cure hepatitis C in over 95% of patients within 8 to 12 weeks, per Clarin.

Yet US hepatitis B newborn vaccination rates have declined steeply over the past two years, according to Time.

What Comes Next: EBV Vaccines and Screening Gaps

Researchers hope the findings will spur prevention research where no tools exist.

There is still no effective vaccine against Epstein-Barr virus, though Lawrence Young, a virologist at the University of Warwick, tells Time that pharmaceutical companies have grown newly interested thanks to EBV's possible role in multiple sclerosis, with several candidates now in clinical trials.

Rumgay says the Kaposi's sarcoma-associated herpesvirus also needs far more prevention research.

Meanwhile, IARC epidemiologist Harriet Rumgay expects future analyses to show the impact of HPV vaccination as cohorts reach the age when cervical cancer typically appears, and WHO targets 90% of girls vaccinated by 15 and 70% of women screened by 2030, per NCHStats.

Sources

  1. time.com › These Infections Are Linked to 12% of New Cancer Cases
  2. clarin.com › New Lancet study links 12% of global cancer cases to 12 infections
  3. nchstats.com › WHO Cancer Study Finds 12% of New Cases Linked to Infections

More on Health